Promoter holding
64.27%
MP
Mks Pharma Limited - Due diligence report
A 360° intelligence report on Mks Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress sig…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Mks Pharma Limited — 360° Intelligence Report
Generated from MCA filings & public records52/100
Trust Score
Moderate
Mks Pharma Limited is assessed as Moderate with a Trust Score of 52/100. Mks Pharma Limited is a public limited indian non-government company incorporated in 2005, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and moderate financial risk profile.
Report generated on 16 Aug 2026 from the latest processed filings. Mks Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
52/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
23/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
40/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 2 satisfied (9.00 Lakh).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Oriental Bank Of Commerce | 2 | 48.0 cr |
Compliance Score: 23/100 Caution Indicated
- Company status is "Amalgamated" - not Active.
- Last balance sheet is for Mar 2017 - filings overdue.
- Litigation present in 1 court forum(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MEENAKSHI GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNIL GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAVI SHANKAR GARG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJAT GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- SUNIL GUPTA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: SANJAY GUPTA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 40
Growth signals & trust indicators
Operating for 21+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (23/100).
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence37/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment54/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view54/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events28 Sep 2017
Last AGM held
Annual general meeting
31 Mar 2017
Latest balance sheet
Filed with ROC
30 Aug 2016
Director ceased
KISHORI LAL GUPTA
20 May 2016
Director appointed
RAJAT GUPTA (Director)
Director ceased
BHAGWAN DASS ARORA
31 Mar 2016
Share transfer (FY 2016)
1.00000000 shares to JITENDER
30 Sep 2015
Director ceased
MEENAKSHI GUPTA
Director ceased
SUNIL GUPTA
17 Aug 2015
Director appointed
MEENAKSHI GUPTA (Director)
Director ceased
MANISH GUPTA
20 Mar 2015
Director appointed
SUNIL GUPTA (Director)
27 May 2013
Securities allotted
500000 Equity Shares Without Differential Rights - 3.75 cr raised
15 May 2013
Director appointed
RAVI SHANKAR GARG (Director)
01 Apr 2013
Director ceased
ARIDUMAN KUMAR JAIN
22 Jun 2012
Charge satisfied
Oriental Bank Of Commerce
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
5 active director(s) / partner(s); review board churn before relying on management continuity.
All 2 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Chattar Impex Private Limited | U36912GJ2010PTC063281 | Surat City, Gujarat, India |
| Forte Impex Private Limited | U51909DL2013PTC257995 | New Delhi, Delhi, India |
| Annapurna Grains Private Limited | U74900WB2009PTC137940 | Kolkata, West Bengal, India |
| Everblink Sales Private Limited | U74900WB2014PTC202670 | Kolkata, West Bengal, India |
| Slj Exim Private Limited | U51900PB2012PTC036669 | Ludhiana, Punjab, India |
| Crispy Edibles And Beverages Private Limited | U15122UP2010PTC040383 | Orai Distt Jalaun, Uttar Pradesh, India |
| Zuri Material Suppliers Private Limited | U51432DL2008PTC176669 | Delhi, Delhi, India |
| Rjn Marketing Private Limited | U51103MH2016PTC273186 | Thane, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Mks Pharma Limited before audits and certifications: compliance score 23/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Mks Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Mks Pharma Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 52/100, distress signals and MSME payment-delay disclosures - know whether Mks Pharma Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Mks Pharma Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Mks Pharma Limited an active company?
Mks Pharma Limited has MCA status “Amalgamated” with a compliance score of 23/100 (Caution Indicated).
Is Mks Pharma Limited financially healthy?
Mks Pharma Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Mks Pharma Limited?
Its overall Trust Score is 52/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Mks Pharma Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.
Does Mks Pharma Limited have loans or charges against its assets?
No open charges - all 2 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Mks Pharma Limited up to date with its ROC filings?
Last balance sheet is for Mar 2017 - filings overdue. Overall compliance score: 23/100 (Caution Indicated).
Is it risky to lend to Mks Pharma Limited?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
